(R)-(2-(2-((3,3-Dibutyl-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine
| Product Name |
(R)-(2-(2-((3,3-Dibutyl-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine
|
| Product Code |
DA-E032-09
|
| Chemical name |
(R)-(2-(2-((3,3-Dibutyl-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine
|
| Synonyms |
3,3-Dibutyl-5-phenyl-7-methylthio-8-(N-{(R)-1-phenyl-1-[N-(hydroxycarbonylmethyl)carbamoyl]methyl} carbamoylmethoxy)-2,3,4,5-tetrahydro-1,5-benzothiazepine; Elobixibat Acid Sulphide Impurity;
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C36H45N3O5S2
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
663.89
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
NA
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
